Optinose to Present at the Cantor Virtual Global Healthcare Conference
Optinose (NASDAQ:OPTN) has announced that CEO Peter Miller will present a company overview and update at the Cantor Virtual Global Healthcare Conference on September 28, 2021, at 8:40 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Optinose (NASDAQ:OPTN) has announced that CEO Peter Miller will present a company overview and update at the Cantor Virtual Global Healthcare Conference on September 28, 2021, at 8:40 a.m. ET. Interested parties can access the live webcast on the Investors page of the Optinose website, with a replay available for 30 days post-event. The company specializes in providing solutions for patients treated by ENT and allergy specialists.
Details
News Market Reaction – OPTN
The recorded move for OPTN in the trading session of this news was +7.27%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
YARDLEY, Pa., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter Miller will present a company overview and business update at the Cantor Virtual Global Healthcare Conference on September 28, 2021, at 8:40 a.m. ET.
To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.
A replay of the webcast will be available for 30 days following the conclusion of the event.
About Optinose
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.
Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.